Vesalius Biocapital III Company Profile

15:09 EDT 20th June 2019 | BioPortfolio

News Articles [14 Associated News Articles listed on BioPortfolio]

Vesalius Biocapital and IFD launch life sciences fund

Amgen Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke

VESALIUS-CV is the Latest Study in Amgen's PROFICIO Clinical Program Investigating the Impact of Repatha on CVD in Multiple Patient Populations Phase 3 Study Will Enroll High-Risk Patients who Have S...

Washington DC/Baltimore: Proximity, Access and DNA Alley

It should be no surprise that the Washington, DC and Baltimore areas are considered strong for life sciences. This is BioSpace’s BioCapital Community Hotbed.

Evotec bei Investoren

Evotec AG ist wieder bei Investoren unterwegs, und nimmt in nächster Zeit an folgenden Konferenzen teil: BioCapital Europe, Amsterdam, Niederlande Datum: Donnerstag, 14. März 2019, Bankhaus Lampe D....

Neurogene launches with $68.5mm Series A round

Rare neurological disease-focused gene therapy start-up Neurogene Inc. launched with a $68.5mm Series A round from investors including Samsara BioCapital, EcorR1 Capital, Cormorant Asset Management, R...

Intercept grosses $10mm through PIPE

Liver disease therapeutics company Intercept Pharmaceuticals Inc. grossed $10mm through the private placement of 119,760 common shares at $83.50 (a 5% discount) to existing shareholder Samsara BioCapi...

VIDEO: Biotech Showcase 2019: VBC III Targets European Therapeutic, Medtech And Digital Health Opportunities

Marc Lohrmann, managing partner of Versalius BioCapital's VBC III  fund, explains how the company is looking to invest in maturing...   

AlloVir gets $121mm via Series B

AlloVir Inc. (formerly ViraCyte; developing cell therapies for virus-associated diseases) raised $121mm through its Series B financing led by Fidelity Management and Research Co., which was joined by ...

Drugs and Medications [0 Results]


PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Andreas Vesalius, the predecessor of neurosurgery: How his progressive scientific achievements affected his professional life and destiny.

Andreas Vesalius, the father of modern anatomy and a predecessor of neuroscience, was a distinguished medical scholar and Renaissance figure of the 16th Century Scientific Revolution. He challenged tr...

Andreas Vesalius and Harvey Cushing: Tradition and Inspiration.

Did Ibn Zuhr (Avenzoar) postulate before Vesalius that liquid collects in ventricles in the hydrocephalus?

This study aimed to present and evaluate the part of Avenzoar's Liber Teisir that pertains to hydrocephalus. Avenzoar was an Andalusian physician prominent in the history of medicine because of the br...

What is the history of the term "azygos vein" in the anatomical terminology?

The term "azygos vein" is in common use in modern anatomical and cardiovascular textbooks to describe the vein which ascends to the right side of the vertebral column in the region of the posterior me...

Enchanted nature, dissected nature: the case of Galen's anatomical theology.

Through the historical portrait of Galen, I argue that even an enchanted nature does not prevent the performance of violence against nature. Galen (129-c. 216 CE), the great physician-philosopher of ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Surgical Planning and Informed Consent

New devices for anatomic studies and 3-D visualization have proven to be useful for pre-operative surgical planning and intra-operative procedures; the hypothesis of our study is that, in ...

Companies [5 Associated Companies listed on BioPortfolio]

Vesalius Biocapital III


Genkyotex is developing first in class, small molecule therapeutics that specifically and selectively inhibit the NOX family of enzymes. Using a unique screening platform, Genkyot...


Apitope International NV, based in Belgium and the UK, is a world-class drug developer of immunotherapies for the treatment of autoimmune and allergic diseases, including multiple...


Mulligan Biocapital AG is an investment firm dedicated to the life sciences with a specific focus on biotechlology with healt care applications.We invest in North Amercn and european biotechnology ven...

BioCapital Limited

BioKapital is a consultancy dedicated to assisting organisations in the biotechnology, healthcare, information technology and life sciences industries with fundraising and to develop their businesses,...

More Information about "Vesalius Biocapital III" on BioPortfolio

We have published hundreds of Vesalius Biocapital III news stories on BioPortfolio along with dozens of Vesalius Biocapital III Clinical Trials and PubMed Articles about Vesalius Biocapital III for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vesalius Biocapital III Companies in our database. You can also find out about relevant Vesalius Biocapital III Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record